Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
1. Labcorp's Q4 2024 adjusted EPS rose to $3.45, beating estimates. 2. Sales grew by 9.8% to $3.33 billion, slightly above consensus. 3. CEO emphasized growth in oncology and women's health sectors. 4. 2025 EPS guidance set at $15.60-$16.40, slightly above expectations. 5. Analyst reiterates Outperform rating, citing favorable macro tailwinds.